Through validation using the MCD mouse model, we observed increased expression of MAFB and CX3CR1 at the RNA and protein levels in liver tissue, further confirming their accuracy in the diagnosis of NAFLD. This evidence concerns the gene MAFB and metabolic dysfunction-associated steatotic liver disease.